Dolan’s grievances with the NBA and its commissioner Adam Silver have continued to mount. What could come next?

The latest revelations about endemic tuition fee fraud have drawn attention once again to a truth policymakers do not want to ...

The girl moving into my Albert St. bedroom is buying all my furniture. I bundled it together for a bargain deal—my bed, desk, chair, and dresser—all for a few hundred dollars. It’s what I did almost ...

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...

2025 at 4:00 pm during Oral Poster Presentation: Research 3 at NKF SCM25, Dr. Wolfgang Winkelmayer will present a poster titled “Vadadustat for Treatment of Anemia in Older vs Younger Patients ...

SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies ...

Data from the ASCENT study of LIQ861 (YUTREPIA™) in PH-ILD patients highlights safety, tolerability, exploratory changes in six-minute walk ...

Two posters will highlight new data from the company’s open-label ASCENT study of LIQ861 (YUTREPIA) in PH-ILD patients with a focus on safety, tolerability, exploratory changes in 6-minute walk ...

Gain Therapeutics' lead drug candidate, GT-02287, is in clinical development for the treatment of Parkinson's disease (PD) with or without a GBA1 mutation. The orally administered, brain-penetrant ...

Thesis Competition began at the University of Queensland in 2008. BYU graduates participate in this tradition every year and attempt the challenge to present their research in under three minutes.